Literature DB >> 12616428

Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer.

Chew-Wun Wu1, Su-Shun Lo, King-Han Shen, Mao-Chih Hsieh, Jen-Hao Chen, Jen-Huey Chiang, Hwai-Jeng Lin, Anna F-Y Li, Wing-Yiu Lui.   

Abstract

Recurrence after curative resection for gastric cancer remains high. We examined its incidence and factors related to recurrence pattern, while trying to avoid the interaction of various factors. A total of 611 gastric cancer patients after resection for curative intent (1988-1995) were analyzed. The result showed that 245 patients had recurrence (40.1%). Cumulative recurrence rates were 53.5%, 80%, 89.0%, 94.7%, 96.3%, 98%, and 99.5% at 1, 2, 3, 4, 5, 6, and 7 years, respectively. Over half of patients with recurrence (123; 50.2%) had an initial single recurrence. Taking single and multiple recurrence together, most recurrences (213; 86.9%) were distant metastases, 110 recurrences (44.9%) were local relapses, and 78 recurrences (49.8%) were both local and distant. Among the distant metastases, 131 patients (53.5%) had peritoneal dissemination, 106 patients (43.3%) had hematogenous metastases, and 70 patients (28.6%) had distant lymphatic spread. Scirrhous-type stromal reaction, serosa invasion, and female gender were factors negatively related to peritoneal recurrence. Medullary-type stromal reaction and male gender showed a preference for locoregional recurrence, and expanding growth tumor commonly led to hematogenous metastasis. Patients who had paraaortic lymph node metastasis were at high risk of developing distant lymphatic recurrence. It is conceivable that the patterns of recurrence and the times to recurrence provide a biological basis for clinical monitoring of patients with the aim of modifying therapeutic modalities.

Entities:  

Mesh:

Year:  2003        PMID: 12616428     DOI: 10.1007/s00268-002-6279-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  57 in total

1.  Laparoscopic low anterior resection for hematogenous rectal metastasis from gastric adenocarcinoma: a case report.

Authors:  Sang Woo Lim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  World J Surg Oncol       Date:  2011-11-11       Impact factor: 2.754

2.  Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance.

Authors:  I-Rue Lai; Pei-Yu Chu; Hsiao-Sheng Lin; Jun-Yang Liou; Yee-Jee Jan; Jen-Chieh Lee; Tang-Long Shen
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 3.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Ramakrishnan Ayloor Seshadri; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

4.  Treatment for isolated loco-regional recurrence of gastric adenocarcinoma: does surgery play a role?

Authors:  Fabio Carboni; Pasquale Lepiane; Roberto Santoro; Riccardo Lorusso; Pietro Mancini; Massimo Carlini; Eugenio Santoro
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

5.  Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery.

Authors:  Yen-Shu Lin; Kuo-Hung Huang; Yuan-Tzu Lan; Wen-Liang Fang; Jen-Hao Chen; Su-Shun Lo; Mao-Chih Hsieh; Anna Fen-Yau Li; Shih-Hwa Chiou; Chew-Wun Wu
Journal:  J Gastrointest Surg       Date:  2013-05-29       Impact factor: 3.452

6.  Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patients.

Authors:  Wen-Liang Fang; Kuo-Hung Huang; Jen-Hao Chen; Su-Shin Lo; Mao-Chih Hsieh; King-Han Shen; Anna Fen-Yau Li; Dau-Ming Niu; Shih-Hwa Chiou; Chew-Wun Wu
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

7.  Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer.

Authors:  Keiichi Fujiya; Masanori Tokunaga; Rie Makuuchi; Noriyuki Nishiwaki; Hayato Omori; Wataru Takagi; Fumiko Hirata; Makoto Hikage; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-10-24       Impact factor: 7.370

8.  Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer.

Authors:  Sheng-Liu Xue; Hua-Fang Su; Xiao-Qu Hu; Xia Deng; Mei-Long Hu; Cong-Ying Xie
Journal:  Oncol Lett       Date:  2012-09-13       Impact factor: 2.967

Review 9.  Highlights of articles published in annals of nuclear medicine 2016.

Authors:  Hossein Jadvar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-28       Impact factor: 9.236

10.  Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.

Authors:  Jeong Won Lee; Sang Mi Lee; Myoung Won Son; Moon-Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.